Genomic instability is a major problem in cancer progression and therapy resistance. Cytura Therapeutics aims to find a solution to stop destabilization of the genome.
View Top Employees from Cytura TherapeuticsWebsite | http://www.cyturatherapeutics.com |
Revenue | $1 million |
Employees | View employees |
Founded | 2018 |
Address | Kloosterstraat 9, Oss, North Brabant, NL |
Industry | Manufacturing General, Drug Discovery, Manufacturing, Pharmaceuticals |
SIC | SIC Code 21 Companies, SIC Code 20 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 3122 Companies, NAICS Code 312 Companies, NAICS Code 31 Companies |
Looking for a particular Cytura Therapeutics employee's phone or email?
The Cytura Therapeutics annual revenue was $1 million in 2024.
Cytura Therapeutics is based in Oss, North Brabant.
The NAICS codes for Cytura Therapeutics are [33, 3122, 312, 31].
The SIC codes for Cytura Therapeutics are [21, 20].